Targeting prognostic proinflammatory biomarkers to improve outcome on IO drugs

Targeting prognostic proinflammatory biomarkers to improve outcome on IO drugs

Bibliographic Details
Main Author:	John Haanen
Format:	Article
Language:	English
Published:	Elsevier 2019-07-01
Series:	ESMO Open
Online Access:	https://esmoopen.bmj.com/content/4/4/e000557.full

Similar Items

E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma
by: Kristina Bielskienė, et al.
Published: (2015-01-01)

Sleep duration, cardiovascular disease, and proinflammatory biomarkers
by: Grandner MA, et al.
Published: (2013-07-01)

Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis
by: Shu Dong MD, et al.
Published: (2019-08-01)

sCLU as prognostic biomarker and therapeutic target in osteosarcoma
by: Jinfeng Ma, et al.
Published: (2019-01-01)

Proinflammatory biomarkers' level and functional genetic polymorphisms in periprosthetic joint infection
by: Bülent Erdemli, et al.
Published: (2018-03-01)

Upregulation of lncRNA NR_046683 Serves as a Prognostic Biomarker and Potential Drug Target for Multiple Myeloma
by: Hang Dong, et al.
Published: (2019-01-01)

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
by: Wenlong Feng, et al.
Published: (2020-05-01)

Prognostic Biomarkers and Target Proteins for Treatment of High-grade Gliomas
by: Sooman, Linda
Published: (2014)

The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma
by: LIN, CHI-MAW, et al.
Published: (2019)

Oesophageal Cancer : strategies to improve outcomes, and identify novel immunological biomarkers and targets
by: Noble, Fergus
Published: (2014)

Circulating levels of proinflammatory mediators as potential biomarkers of post-traumatic knee osteoarthritis development
by: Svetlana B. Panina, et al.
Published: (2017-10-01)

Predictive value of serum proinflammatory biomarkers in respiratory infections in children and clinical-therapeutic correlations
by: Titiana Cornelia Cotoi, et al.
Published: (2020-06-01)

Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets
by: Marçal ePastor-Anglada, et al.
Published: (2015-02-01)

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
by: Wenjie Tao, et al.
Published: (2021-08-01)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
by: Jiacheng Huang, et al.
Published: (2021-08-01)

Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer
by: Maria Frantzi, et al.
Published: (2020-08-01)

Host-Based Prognostic Biomarkers to Improve Risk Stratification and Outcome of Febrile Children in Low- and Middle-Income Countries
by: Núria Balanza, et al.
Published: (2020-09-01)

Prognostic significance of proinflammatory factors in patients with progressive angina pectoris and type 2 diabetes mellitus
by: Olga Leonidovna Barbarash, et al.
Published: (2012-12-01)

Biomarkers Suggesting Favorable Prognostic Outcomes in Sudden Sensorineural Hearing Loss
by: Jeon Gang Doo, et al.
Published: (2020-09-01)

Assessing the Proinflammatory Cytokines Inhibit Erythropoietin Receptor Expression with Drug Treatment
by: Hsiang-Yu, Chang, et al.
Published: (2015)

THE PROGNOSTIC MODEL OF ANTITUMOR EFFECT OF TARGETED DRUGS IN IMMUNOTHERAPY
by: V. V. Burlyaev, et al.
Published: (2016-08-01)

Gene Ontology Analysis for Drug Targets of the Whole Genome Transcriptome of Human Vascular Endothelial Cells in Response to Proinflammatory IL-1
by: Tom Skaria, et al.
Published: (2019-04-01)

Evaluation of BODE index and its relationship with systemic inflammation mediated by proinflammatory biomarkers in patients with COPD
by: Khan NA, et al.
Published: (2016-11-01)

Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators
by: Claudio Blasi, et al.
Published: (2012-01-01)

Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors
by: Gustavo Rodrigues Martins, et al.
Published: (2016-01-01)

Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
by: Weina Kong, et al.
Published: (2021-07-01)

Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer
by: Liu F, et al.
Published: (2021-01-01)

Role of Anillin in Tumour: From a Prognostic Biomarker to a Novel Target
by: Nguyen Minh Tuan, et al.
Published: (2020-06-01)

CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
by: Alexandra Landras, et al.
Published: (2019-11-01)

Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
by: Lu-yang Zhang, et al.
Published: (2019-09-01)

Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer
by: Irantzu Gorroño-Etxebarria, et al.
Published: (2019-06-01)

Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer
by: Lan, L., et al.
Published: (2022)

MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma
by: Tianyu Wang, et al.
Published: (2021-09-01)

Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19
by: Yamilé López-Hernández, et al.
Published: (2021-07-01)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
by: Xuezhi Zhou, et al.
Published: (2021-03-01)

Drug targets and predictive biomarkers in the management of metastatic melanoma
by: Thumar J, et al.
Published: (2012-09-01)

Drug targets and lipid biomarkers of hyperlipidemia associated diseases
by: Sneha Rai, et al.
Published: (2017-10-01)

The Holistic Targeting (HOT) methodology as the means to improve Information Operations (IO) target development and prioritization
by: Ieva, Christopher S.
Published: (2012)

Proinflammatory and Hepatic Features Related to Morbidity and Fatal Outcomes in COVID-19 Patients
by: Omar Ramos-Lopez, et al.
Published: (2021-07-01)

Drug Targets to Improve the Outcome of Hormonal Adjuvant Therapy in Breast and Prostate Cancers
by: Chari, Venkatesh Vasu
Published: (2013)